Already a Bloomberg.com user?
Sign in with the same account.
PLAINSBORO TOWNSHIP, N.J. (AP) — In a July 9 story about Indian drugmaker Ranbaxy Laboratories Ltd., The Associated Press erroneously reported that the company will launch a generic version of acne drug Accutane in about six months. The product is slightly different than Accutane and will be sold under the brand name Absorica.